bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ...

13
Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 85 1 2 3 4 5 6 3250 40 51.2 46.9 1.9 20 25 65 35 Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab Jamahiriya ABSTRACT We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2% were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%). [email protected], [email protected], [email protected] 08/02/06 قبول:؛ ال26/07/05 م:ست ا(1) Huda Kutrani. Department of Information Technology, Faculty of Public Health, Garyounis University, Benghazi; (2) Abdulsalam El-Gatit. Departments of Surgery & Cardiovascular Unit, Faculty of Medicine, Omar Almokhtar University, Al Batnan Medical Center, Tobruq; (3) Amina Shekhteryea. Department of Health Administration, Faculty of Public Health, Garyounis University, Benghazi; (4) Yousef El-Gitait. Department of Health Administration, High Institute of Medical Technology, Misurata; (5) Omar Sudani. Faculty of Public Health, Garyounis University, Benghazi; (6) Saad Akoub. Al Batnan Medical Center, Tobruq, Libyan Arab Jamahiriya. Facteurs démographiques influant sur l’infection par les virus des hépatites B et C à Benghazi (Jamahiriya arabe libyenne) RÉSUMÉ Nous avons analysé l’épidémiologie des hépatites B et C dans un échantillon de patients adressés au Service des Maladies infectieuses et endémiques du Al Jamahiriya Hospital de Benghazi. Sur un total de 3250 patients, 40 % ont été sélectionnés par randomisation. Sur cet effectif sélectionné, 51,2 % étaient infectés par le virus de l’hépatite B, 46,9 % par le virus de l’hépatite C et 1,9 % par les deux virus B et C. Les patients les plus jeunes et les célibataires se sont avérés davantage sujets à l’hépatite B, tandis que l’âge, le mariage et la qualité de voyageur semblent prédisposer à l’hépatite C. Environ 20 % des cas d’hépatite B et 25 % des cas d’hépatite C n’étaient pas de nationalité libyenne. Ces infections touchent en plus forte proportion les hommes (65 %) que les femmes (35 %).

Transcript of bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ...

Page 1: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 85

123456

32504051.2

46.91.9

20

25

6535

Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab JamahiriyaABSTRACT We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2%were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%).

[email protected], [email protected], [email protected]/07/0508/02/06

(1) Huda Kutrani. Department of Information Technology, Faculty of Public Health, Garyounis University, Benghazi; (2) Abdulsalam El-Gatit. Departments of Surgery & Cardiovascular Unit, Faculty of Medicine, Omar Almokhtar University, Al Batnan Medical Center, Tobruq; (3) Amina Shekhteryea. Department of Health Administration, Faculty of Public Health, Garyounis University, Benghazi; (4) Yousef El-Gitait. Department of Health Administration, High Institute of Medical Technology, Misurata; (5) Omar Sudani. Faculty of Public Health, Garyounis University, Benghazi; (6) Saad Akoub. Al Batnan Medical Center, Tobruq, Libyan Arab Jamahiriya.

Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab JamahiriyaABSTRACT We studied the epidemiology of hepatitis B and C infection among a sample of patients referred to the Department of the Infectious and Endemic Diseases at Al Jamahiriya Hospital in Benghazi. Of a total 3250 patients, 40% were randomly selected. Of these, 51.2% were infected with hepatitis B virus, 46.9% with hepatitis C virus and 1.9% with hepatitis B and C. Younger patients and single patients were more prone to hepatitis B infection, while older patients, married patients and travellers were more prone to hepatitis C. About 20% of hepatitis B cases and 25% of hepatitis C cases were non-Libyans. Males were more affected (65%) than females (35%).

[email protected], [email protected], [email protected]

االستالم: 26/07/05؛ القبول: 08/02/06(1) Huda Kutrani. Department of Information Technology, Faculty of Public Health, Garyounis University, Benghazi; (2) Abdulsalam El-Gatit. Departments of Surgery & Cardiovascular Unit, Faculty of Medicine, Omar Almokhtar University, Al Batnan Medical Center, Tobruq; (3) Amina Shekhteryea. Department of Health Administration, Faculty of Public Health, Garyounis University, Benghazi; (4) Yousef El-Gitait. Department of Health Administration, High Institute of Medical Technology, Misurata; (5) Omar Sudani. Faculty of Public Health, Garyounis University, Benghazi; (6) Saad Akoub. Al Batnan Medical Center, Tobruq, Libyan Arab Jamahiriya.

Facteurs démographiques influant sur l’infection par les virus des hépatites B et C à Benghazi (Jamahiriya arabe libyenne)RÉSUMÉ Nous avons analysé l’épidémiologie des hépatites B et C dans un échantillon de patients adressés au Service des Maladies infectieuses et endémiques du Al Jamahiriya Hospital de Benghazi. Sur un total de 3250 patients, 40 % ont été sélectionnés par randomisation. Sur cet effectif sélectionné, 51,2 % étaient infectés par le virus de l’hépatite B, 46,9 % par le virus de l’hépatite C et 1,9 % par les deux virus B et C. Les patients les plus jeunes et les célibataires se sont avérés davantage sujets à l’hépatite B, tandis que l’âge, le mariage et la qualité de voyageur semblent prédisposer à l’hépatite C. Environ 20 % des cas d’hépatite B et 25 % des cas d’hépatite C n’étaient pas de nationalité libyenne. Ces infections touchent en plus forte proportion les hommes (65 %) que les femmes (35 %).

Page 2: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

86 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

2

8-16

2.42.780,000

160,000

]1[0.81.40.30.8

1.80.9-1.24.2

1.32.4

256.8]2[1.6]3[

20.5]3[

30444266

7.9540014847

336Lancet716.6

12.97

1300

19982002

2003

Page 3: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 87

3

Rapidenzyme-linked immunosorbent assay:

ELISAPCR87467.2ELISAPCR23217.9Rapid

19414.9

t-testP

1300

665

51.261046.9251.9

8628.540.7)0.05 <P

42.90.05 <P

315

154546

15450.05 <P460.05 < P

0.05 < P(

0.05 < P1

Page 4: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

88 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

4

117

529

19 14

295301

0 1015

0

100

200

300

400

500

600

<15 15-45 =>46

1

84265.8458.235

0.05 < P

46135.520415.7

246

18.936428.0

0.05 < P

171.30.60.05 < P1

91370.2

38729.80.05 < P

47036.219515.00.05 < P

42632.8

18414.20.05 < P

171.3

8

0.60.05 < P(1)

81851.3

48237.00.05 < P

34126.2324

24.92

4

117

529

19 14

295301

0 1015

0

100

200

300

400

500

600

<15 15-45 46

1

8426545835

0.05 < P

46135.4620415.7

246

18.9236428

0.05 < P

171.310.610.05 < P1

91370.23

38729.770.05 < P

47036.16

195150.05 < P

42632.77

18414.150.05 < P

171.31

8

0.610.05 < P1

Page 5: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 89

5

45735.2

15311.80.05 < P

201.6

50.41

101978.428121.60.05 < P

1249.5

54141.60.05 < P

15211.7458

35.20.05<P

50.4

201.51

56843.70.05<P36528.00.05 < P154

11.90.05<P14611.20.05<P89

6.90.05<P100.8

0.05<P

32525.00.05<P135

10.40.05<P826.30.05<P302.3

0.05<P60.460.05<P

23017.7

0.05<P22217.1

644.90.05<P584.5

322.50.05<P40.30.05<P

131.00.05<P80.60.05<P

30.20.05<P10.070.05<P

0.05<P1

Page 6: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

90 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

Page 7: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 91

7

101678.228421.90.05 < P

634.9

493.80.05 < P17

1.30.05 < P

806.20.05<P

493.80.05 < P171.3

30.22

2

17)1.3(17)1.3(3)0.2(

49)3.8(80)6.2(3)0.2(

63)4.8(49)3.8(3)0.2(

536)41.2(

464)35.7(

16)1.2(

665)51.2(

610)46.9(

25)1.9(

463.6

292.214

1.10.05 < P

40.33

86666.60.05 < P

21616.60.05 < P

18013.90.05 < P382.90.05 < P

7

101678.228421.90.05 < P

634.9

493.80.05 < P17

1.30.05 < P

806.20.05<P

493.80.05 < P171.3

30.22

2

17)1.3(17)1.3(3)0.2(

49)3.8(80)6.2(3)0.2(

63)4.8(49)3.8(3)0.2(

536)41.2(

464)35.7(

16)1.2(

665)51.2(

610)46.9(

25)1.9(

463.6

292.214

1.10.05 < P

40.33

86666.60.05 < P

21616.60.05 < P

18013.90.05 < P382.90.05 < P

8

1

2

3

101678.228421.90.05 < P

634.9

493.80.05 < P17

1.30.05 < P

806.20.05<P

493.80.05 < P171.3

30.22

2

17)1.3(17)1.3(3)0.2(

49)3.8(80)6.2(3)0.2(

63)4.8(49)3.8(3)0.2(

536)41.2(464)35.7(16)1.2(

665)51.2(610)46.9(25)1.9(

463.6

292.214

Page 8: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

92 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

8

43233.2)0.05 < P1118.5

0.05 < P98

7.50.05 < P241.90.05 < P

231.80.05 < P

0.070.0723

24

11198

432

10581

13

411

01 123

0

50

100

150

200

250

300

350

400

450

500

No.

of P

atie

nts

B C B & C

2

133130010.2116789.80.05 < P

312.466563448.80.05<P967.4

61051439.50.05 < P

60.46

25191.50.05 < P

7.4

2.40.05 < P

0.05 < P3

Page 9: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 93

9

584.51242

95.50.05 < P

292.263649.0

0.05 < P

292.258144.70.05 < P

0.05 < P3

3

29)2.2(14)1.1(4)0.3(

636)48.9(

596)45.8(21)1.6(

31)2.4(96)7.4(6)0.5(

634)48.8(

514)39.5(19)1.5(

29)2.2(29)2.2(0)0(

636)48.9(

581)44.7(25)1.9(

)1(P = 0.000

)2(

4

9

584.51242

95.50.05 < P

292.263649.0

0.05 < P

292.258144.70.05 < P

0.05 < P3

3

29)2.2(14)1.1(4)0.3(

636)48.9(

596)45.8(21)1.6(

31)2.4(96)7.4(6)0.5(

634)48.8(

514)39.5(19)1.5(

29)2.2(29)2.2(0)0(

636)48.9(

581)44.7(25)1.9(

)1(P = 0.000

)2(

4

Page 10: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

94 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

10

5

)3(

4

5

)4(9.511.7

45

)5(4

5

)6(2.4

37.430.05 < P

4

PdfWald S.E

0.893 10.018 0.597 0.08-

0.000 126.898 0.006 0.03-

0.023 15.161 0.14 0.318-

0.026 14.985 0.184 0.411

0.034 14.517 0.163 0.347-

0.000 122.335 0.243 1.147-

2= 290.639d.f = 16P = 0.000

Page 11: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 95

11

5

PdfWald S.E

0.787 10.073 0.601 0.163

0.000 127.578 0.006 0.031

0.037 14.355 0.140 0.293

0.018 15.577 0.185 0.438-

0.019 15.521 0.162 0.382

0.000 126.938 0.251 1.303

2= 298.195d.f = 16P = 0.000

ELISAPCR

Rapid

]38[

genotype

]910[

13

5

PdfWald S.E

0.787 10.073 0.601 0.163

0.000 127.578 0.006 0.031

0.037 14.355 0.140 0.293

0.018 15.577 0.185 0.438-

0.019 15.521 0.162 0.382

0.000 126.938 0.251 1.303

2= 298.195d.f = 16P = 0.000

ELISAPCR

Rapid

]38[

genotype

]910[

Page 12: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

96 La Revue de Santé de la Méditerranée orientale, Vol. 13, No 1, 2007

References

1. Kane A, et al. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization, 1999, 77:801–7.

2.

.1998

3. Daw MA et al. Prevalence of hepatitis C virus antibodies among different popula--

tions of relative and attributable risk. Saudi medical journal, 2002, 23(11):1356–60.

4. Daw MA et al. Seroepidemiology of hepatitis B virus markers among hos--p i t a l h e a l t h c a r e w o r k e r s . A n a l y --sis of certain potential risk factors. Saudi medical journal, 2000, 21(12): 1157–60.

5. Saleh MG et al. High prevalence of hepa--titis C virus in the normal Libyan popula--tion. Transactions of the Royal Society

14

]3-5[

clinical audits

References

1. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization, 1999, 77:801 7.

2.1998

3. Daw MA et al. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi medical journal, 2002, 23(11):1356–60.

4. Daw MA et al. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors. Saudi medical journal, 2000, 21(12): 1157–60.

5. Saleh MG et al. High prevalence of hepatitis C virus in the normal Libyan population. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88(3):292–4.

6. Yerly S et al. Nosocomial outbreak of multiple bloodborne viral infections. Journal ofinfectious diseases, 2001, 184(3):369–72.

7. Wyatt GB. Pregnancy hepatitis in Libya. Lancet, 197, 1(8023):1204–5.

8. Hong Z et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992–2003. European journal of clinical microbiology & infectious diseases, 2005, 24(7):464–70.

9. Okamoto K et al. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Journal ofgastroenterology and hepatology, 2005, 20(7):1102–8.

10. Verschuere V, Yap PS, Fevery J. Is HBV genotyping of clinical relevance? Acta gastro-enterologica Belgica, 2005, 68(2):233–6.

11. Chiaramonte M et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case–control study in Italy. Journal of hepatology, 1996, 24:129 34.

12

]1112[

]34[

]6[

3

]3-5[

clinical audits

Page 13: bF³¶= L>E>ÃJ¶= ÏÆb¢ Ìfë[MÖ = Íɪ=f¦Ç b¶= ¸º=Ç£¶= ÍÉFÉ ...applications.emro.who.int/emhj/1301/13_1_2007_85_97.pdf · Garyounis University, Benghazi; (2) Abdulsalam

Eastern Mediterranean Health Journal, Vol. 13, No. 1, 2007 97

of Tropical Medicine and Hygiene, 1994, 88(3):292–4.

6. Yerly S et al. Nosocomial outbreak of mul--tiple bloodborne viral infections. Journal of infectious diseases, 2001, 184(3):369–72.

7. Wyatt GB. Pregnancy hepatitis in Libya. Lancet, 197, 1(8023):1204–5.

8. Hong Z et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992–2003. European journal of clinical microbiology & infectious dis--eases, 2005, 24(7):464–70.

9. Okamoto K et al. Association of functional gene polymorphisms of matrix metallo--proteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Journal of gastroenterology and hepatology, 2005, 20(7):1102–8.

10. Verschuere V, Yap PS, Fevery J . Is HBV genotyping of clinical relevance? Acta gastro-enterologica Belgica, 2005, 68(2):233–6.

11. Chiaramonte M et al. Risk factors in com--munity-acquired chronic hepatitis C virus infection: a case–control study in Italy. Journal of hepatology, 1996, 24:129–34.